Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 1
2017 4
2018 1
2019 1
2020 11
2021 6
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Dimethyl fumarate modulates the dystrophic disease program following short-term treatment.
Timpani CA, Kourakis S, Debruin DA, Campelj DG, Pompeani N, Dargahi N, Bautista AP, Bagaric RM, Ritenis EJ, Sahakian L, Debrincat D, Stupka N, Hafner P, Arthur PG, Terrill JR, Apostolopoulos V, de Haan JB, Guven N, Fischer D, Rybalka E. Timpani CA, et al. JCI Insight. 2023 Nov 8;8(21):e165974. doi: 10.1172/jci.insight.165974. JCI Insight. 2023. PMID: 37751291 Free PMC article.
Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy.
Kourakis S, Timpani CA, de Haan JB, Gueven N, Fischer D, Rybalka E. Kourakis S, et al. Among authors: timpani ca. Redox Biol. 2021 Jan;38:101803. doi: 10.1016/j.redox.2020.101803. Epub 2020 Nov 18. Redox Biol. 2021. PMID: 33246292 Free PMC article. Review.
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
Kourakis S, Timpani CA, de Haan JB, Gueven N, Fischer D, Rybalka E. Kourakis S, et al. Among authors: timpani ca. Pharmaceuticals (Basel). 2020 Oct 13;13(10):306. doi: 10.3390/ph13100306. Pharmaceuticals (Basel). 2020. PMID: 33066228 Free PMC article. Review.
Adenylosuccinic Acid: An Orphan Drug with Untapped Potential.
Rybalka E, Kourakis S, Bonsett CA, Moghadaszadeh B, Beggs AH, Timpani CA. Rybalka E, et al. Among authors: timpani ca. Pharmaceuticals (Basel). 2023 May 31;16(6):822. doi: 10.3390/ph16060822. Pharmaceuticals (Basel). 2023. PMID: 37375769 Free PMC article.
28 results